1,3,4-oxadiazole has been researched along with chalcone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Gan, X; Hu, D; Song, B; Wang, Y | 1 |
| Abbas, SH; Abd El-Hafeez, AA; Abdel-Aziz, M; Abdelhamid, D; Fathi, MAA; Montano, MM | 1 |
| Bhandari, S; Patil, S | 1 |
| Abbas, SH; Abdel-Aziz, M; Abdelhamid, D; Gomaa, HAM; Hagar, FF; Youssif, BGM | 1 |
1 review(s) available for 1,3,4-oxadiazole and chalcone
| Article | Year |
|---|---|
A Review: Discovering 1,3,4-oxadiazole and Chalcone Nucleus for Cytotoxicity / EGFR Inhibitory Anticancer Activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Structure; Neoplasms; Oxadiazoles; Structure-Activity Relationship | 2022 |
3 other study(ies) available for 1,3,4-oxadiazole and chalcone
| Article | Year |
|---|---|
Synthesis and antiviral evaluation of novel 1,3,4-oxadiazole/thiadiazole-chalcone conjugates.
Topics: Antiviral Agents; Chalcone; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Structure-Activity Relationship; Thiadiazoles; Tobacco Mosaic Virus | 2017 |
1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Interleukin-6; Molecular Structure; Oxadiazoles; Protein Kinase Inhibitors; STAT3 Transcription Factor; Structure-Activity Relationship | 2019 |
New 1,3,4-oxadiazole-chalcone/benzimidazole hybrids as potent antiproliferative agents.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship | 2023 |